Cargando…
Intravenous thrombolytic therapy for acute ischemic stroke in Hubei, China: a survey of thrombolysis rate and barriers
BACKGROUND: Rates of thrombolysis in most countries are well below best practice benchmarks. We aimed to investigate thrombolysis utilization and its associated factors in acute ischemic stroke (AIS) patients in Hubei province, China, to assess neurologists’ experiences of the treatment, and to iden...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6704516/ https://www.ncbi.nlm.nih.gov/pubmed/31438899 http://dx.doi.org/10.1186/s12883-019-1418-z |
_version_ | 1783445516756975616 |
---|---|
author | Zhou, Yanfeng Yan, Shijiao Song, Xingyue Gong, Yanhong Li, Wenzhen Wang, Mengdie Yin, Xiaoxv Hu, Bo Lu, Zuxun |
author_facet | Zhou, Yanfeng Yan, Shijiao Song, Xingyue Gong, Yanhong Li, Wenzhen Wang, Mengdie Yin, Xiaoxv Hu, Bo Lu, Zuxun |
author_sort | Zhou, Yanfeng |
collection | PubMed |
description | BACKGROUND: Rates of thrombolysis in most countries are well below best practice benchmarks. We aimed to investigate thrombolysis utilization and its associated factors in acute ischemic stroke (AIS) patients in Hubei province, China, to assess neurologists’ experiences of the treatment, and to identify barriers against the treatment from perspective of AIS patients and neurologists. METHODS: Survey of 2096 AIS patients and 709 neurologists from 66 hospitals was conducted in Hubei province between 2014 and 2015. A multivariable logistic regression model was utilized to identify the factors associated with thrombolysis utilization and neurologists’ experiences with thrombolysis. RESULTS: Of the 2096 AIS patients, only 3.8% received thrombolysis. Of the 709 neurologists, 66.0% reported using thrombolysis for AIS patients. The main reasons for not using thrombolysis were late arrival of patients, fear of the risk of complications of thrombolysis, and light or quickly recovered stroke symptoms. The behavior and clinical characteristics of patients, including early admission to hospital (odds ratio [OR] = 5.81, 95% confidence intervals [CI] 3.31–10.20), using emergency medical services to be hospitalized (OR = 3.36, 95% CI 2.00–5.62), stroke history (OR = 0.53, 95% CI 0.28–0.99), and National Institute of Health Stroke Scale score < 4 (OR = 0.46, 95% CI 0.27–0.77) were shown to significantly affect the thrombolysis utilization in the multivariate model. In addition, hospital grade (OR = 2.84, 95% CI 1.84–4.37), education level (OR = 2.49, 95% CI 1.09–5.73), and working years (OR = 1.88, 95% CI 1.18–3.00) were strongly associated with neurologists’ experiences of thrombolysis. CONCLUSIONS: A very low proportion of AIS patients received thrombolysis in Hubei province, China. Considerable education programs and interventions were required regarding knowledge of stroke treatment for clinicians and proper behavior after stroke for AIS patients and their families. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12883-019-1418-z) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-6704516 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-67045162019-08-22 Intravenous thrombolytic therapy for acute ischemic stroke in Hubei, China: a survey of thrombolysis rate and barriers Zhou, Yanfeng Yan, Shijiao Song, Xingyue Gong, Yanhong Li, Wenzhen Wang, Mengdie Yin, Xiaoxv Hu, Bo Lu, Zuxun BMC Neurol Research Article BACKGROUND: Rates of thrombolysis in most countries are well below best practice benchmarks. We aimed to investigate thrombolysis utilization and its associated factors in acute ischemic stroke (AIS) patients in Hubei province, China, to assess neurologists’ experiences of the treatment, and to identify barriers against the treatment from perspective of AIS patients and neurologists. METHODS: Survey of 2096 AIS patients and 709 neurologists from 66 hospitals was conducted in Hubei province between 2014 and 2015. A multivariable logistic regression model was utilized to identify the factors associated with thrombolysis utilization and neurologists’ experiences with thrombolysis. RESULTS: Of the 2096 AIS patients, only 3.8% received thrombolysis. Of the 709 neurologists, 66.0% reported using thrombolysis for AIS patients. The main reasons for not using thrombolysis were late arrival of patients, fear of the risk of complications of thrombolysis, and light or quickly recovered stroke symptoms. The behavior and clinical characteristics of patients, including early admission to hospital (odds ratio [OR] = 5.81, 95% confidence intervals [CI] 3.31–10.20), using emergency medical services to be hospitalized (OR = 3.36, 95% CI 2.00–5.62), stroke history (OR = 0.53, 95% CI 0.28–0.99), and National Institute of Health Stroke Scale score < 4 (OR = 0.46, 95% CI 0.27–0.77) were shown to significantly affect the thrombolysis utilization in the multivariate model. In addition, hospital grade (OR = 2.84, 95% CI 1.84–4.37), education level (OR = 2.49, 95% CI 1.09–5.73), and working years (OR = 1.88, 95% CI 1.18–3.00) were strongly associated with neurologists’ experiences of thrombolysis. CONCLUSIONS: A very low proportion of AIS patients received thrombolysis in Hubei province, China. Considerable education programs and interventions were required regarding knowledge of stroke treatment for clinicians and proper behavior after stroke for AIS patients and their families. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12883-019-1418-z) contains supplementary material, which is available to authorized users. BioMed Central 2019-08-22 /pmc/articles/PMC6704516/ /pubmed/31438899 http://dx.doi.org/10.1186/s12883-019-1418-z Text en © The Author(s). 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Article Zhou, Yanfeng Yan, Shijiao Song, Xingyue Gong, Yanhong Li, Wenzhen Wang, Mengdie Yin, Xiaoxv Hu, Bo Lu, Zuxun Intravenous thrombolytic therapy for acute ischemic stroke in Hubei, China: a survey of thrombolysis rate and barriers |
title | Intravenous thrombolytic therapy for acute ischemic stroke in Hubei, China: a survey of thrombolysis rate and barriers |
title_full | Intravenous thrombolytic therapy for acute ischemic stroke in Hubei, China: a survey of thrombolysis rate and barriers |
title_fullStr | Intravenous thrombolytic therapy for acute ischemic stroke in Hubei, China: a survey of thrombolysis rate and barriers |
title_full_unstemmed | Intravenous thrombolytic therapy for acute ischemic stroke in Hubei, China: a survey of thrombolysis rate and barriers |
title_short | Intravenous thrombolytic therapy for acute ischemic stroke in Hubei, China: a survey of thrombolysis rate and barriers |
title_sort | intravenous thrombolytic therapy for acute ischemic stroke in hubei, china: a survey of thrombolysis rate and barriers |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6704516/ https://www.ncbi.nlm.nih.gov/pubmed/31438899 http://dx.doi.org/10.1186/s12883-019-1418-z |
work_keys_str_mv | AT zhouyanfeng intravenousthrombolytictherapyforacuteischemicstrokeinhubeichinaasurveyofthrombolysisrateandbarriers AT yanshijiao intravenousthrombolytictherapyforacuteischemicstrokeinhubeichinaasurveyofthrombolysisrateandbarriers AT songxingyue intravenousthrombolytictherapyforacuteischemicstrokeinhubeichinaasurveyofthrombolysisrateandbarriers AT gongyanhong intravenousthrombolytictherapyforacuteischemicstrokeinhubeichinaasurveyofthrombolysisrateandbarriers AT liwenzhen intravenousthrombolytictherapyforacuteischemicstrokeinhubeichinaasurveyofthrombolysisrateandbarriers AT wangmengdie intravenousthrombolytictherapyforacuteischemicstrokeinhubeichinaasurveyofthrombolysisrateandbarriers AT yinxiaoxv intravenousthrombolytictherapyforacuteischemicstrokeinhubeichinaasurveyofthrombolysisrateandbarriers AT hubo intravenousthrombolytictherapyforacuteischemicstrokeinhubeichinaasurveyofthrombolysisrateandbarriers AT luzuxun intravenousthrombolytictherapyforacuteischemicstrokeinhubeichinaasurveyofthrombolysisrateandbarriers |